CANTON, Mass., Jan. 4, 2017 /PRNewswire/ — Apligraf® – an FDA-approved, bioengineered living-cell therapy from Organogenesis Inc. – has become the first wound-healing therapy to demonstrate a significant change in the genomic profile of a treated non-healing wound, according to new research published in the peer-reviewed journal Science Translational Medicine. The analysis from a multidisciplinary […]